Yingna Cai

458 total citations
9 papers, 359 citations indexed

About

Yingna Cai is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Yingna Cai has authored 9 papers receiving a total of 359 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Oncology and 3 papers in Pharmacology. Recurrent topics in Yingna Cai's work include Pharmacogenetics and Drug Metabolism (3 papers), Cancer therapeutics and mechanisms (2 papers) and Carcinogens and Genotoxicity Assessment (2 papers). Yingna Cai is often cited by papers focused on Pharmacogenetics and Drug Metabolism (3 papers), Cancer therapeutics and mechanisms (2 papers) and Carcinogens and Genotoxicity Assessment (2 papers). Yingna Cai collaborates with scholars based in United States, Canada and United Kingdom. Yingna Cai's co-authors include John DiGiovanni, Linus L. Shen, Robert K. Flamm, Angela M. Nilius, Laurel S. Almer, Jill Beyer, Sanro Tachibana, M. Eileen Dolan, Meng Xu‐Welliver and Susan M. Ludeman and has published in prestigious journals such as Clinical Cancer Research, Antimicrobial Agents and Chemotherapy and Frontiers in Microbiology.

In The Last Decade

Yingna Cai

9 papers receiving 340 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yingna Cai United States	7	162	74	70	62	61	9	359
Michael Wong United States	13	226 1.4×	44 0.6×	77 1.1×	50 0.8×	32 0.5×	22	549
Denis Platel France	11	228 1.4×	38 0.5×	66 0.9×	41 0.7×	52 0.9×	13	430
Kiran Dole United States	13	247 1.5×	50 0.7×	25 0.4×	79 1.3×	34 0.6×	22	532
Nguyen Thi Thu Hang Vietnam	14	175 1.1×	81 1.1×	36 0.5×	141 2.3×	70 1.1×	26	482
David Pereira United States	10	117 0.7×	52 0.7×	36 0.5×	63 1.0×	24 0.4×	13	364
Lianchun Li China	13	284 1.8×	46 0.6×	56 0.8×	49 0.8×	17 0.3×	24	445
Tomotaka Okubo Japan	10	191 1.2×	34 0.5×	32 0.5×	20 0.3×	56 0.9×	28	370
Adriel Villegas‐Estrada United States	6	156 1.0×	65 0.9×	63 0.9×	165 2.7×	10 0.2×	8	465
D. Rosi United States	10	190 1.2×	131 1.8×	28 0.4×	82 1.3×	53 0.9×	14	438
Alfonso Barreto Colombia	16	328 2.0×	35 0.5×	23 0.3×	51 0.8×	45 0.7×	42	664

Countries citing papers authored by Yingna Cai

Since Specialization

Citations

This map shows the geographic impact of Yingna Cai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yingna Cai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yingna Cai more than expected).

Fields of papers citing papers by Yingna Cai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yingna Cai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yingna Cai. The network helps show where Yingna Cai may publish in the future.

Co-authorship network of co-authors of Yingna Cai

This figure shows the co-authorship network connecting the top 25 collaborators of Yingna Cai. A scholar is included among the top collaborators of Yingna Cai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yingna Cai. Yingna Cai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Liu, Ge, Jiapeng Xu, Yuanyuan Huang, et al.. (2024). Ammonium sulfate denatures transport medium less dependent on guanidinium isothiocyanate and enables SARS-CoV-2 RNA and antigen detection compatibility. Frontiers in Microbiology. 15. 1384991–1384991. 1 indexed citations

Hande, Kenneth R., A. Hagey, Jordan Berlin, et al.. (2006). The Pharmacokinetics and Safety of ABT-751, a Novel, Orally Bioavailable Sulfonamide Antimitotic Agent: Results of a Phase 1 Study. Clinical Cancer Research. 12(9). 2834–2840. 71 indexed citations

Shen, Linus L., et al.. (2005). Mechanism of Action of a Novel Series of Naphthyridine-Type Ribosome Inhibitors: Enhancement of tRNA Footprinting at the Decoding Site of 16S rRNA. Antimicrobial Agents and Chemotherapy. 49(5). 1890–1897. 6 indexed citations

Gu, Yu, Alan S. Florjancic, Richard F. Clark, et al.. (2003). Structure–activity relationships of novel potent MurF inhibitors. Bioorganic & Medicinal Chemistry Letters. 14(1). 267–270. 42 indexed citations

Nilius, Angela M., Linus L. Shen, Laurel S. Almer, et al.. (2003). In Vitro Antibacterial Potency and Spectrum of ABT-492, a New Fluoroquinolone. Antimicrobial Agents and Chemotherapy. 47(10). 3260–3269. 100 indexed citations

Cai, Yingna, Craig B. Marcus, F. Peter Guengerich, Harry V. Gelboin, & William M. Baird. (2000). Roles of Cytochrome P450 1A1 and 1B1 in Metabolic Activation of Dibenzo[a, l]Pyrene by Microsomes from the Human Mammary Carcinoma Cell Line MCF-7. Polycyclic aromatic compounds. 16(1-4). 109–118. 2 indexed citations

Cai, Yingna, Michael H. Wu, Meng Xu‐Welliver, et al.. (2000). Effect of O6-benzylguanine on alkylating agent-induced toxicity and mutagenicity. In Chinese hamster ovary cells expressing wild-type and mutant O6-alkylguanine-DNA alkyltransferases.. PubMed. 60(19). 5464–9. 41 indexed citations

Cai, Yingna, et al.. (1996). Mechanism-Based Inactivation of Hepatic Ethoxyresorufin O-Dealkylation Activity by Naturally Occurring Coumarins. Chemical Research in Toxicology. 9(4). 729–736. 44 indexed citations

Cai, Yingna, et al.. (1993). Inhibition and inactivation of murine hepatic ethoxy- and pentoxyresorufin O-dealkylase by naturally occurring coumarins. Chemical Research in Toxicology. 6(6). 872–879. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact